{"organizations": [], "uuid": "03e2b105d71cb61a5a6993c65de92dfca841add0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sun-pharmaceutical-industries-anno/brief-sun-pharmaceutical-industries-announces-settlement-of-patent-litigation-for-generic-linzess-in-u-s-idUSFWN1PB0UD", "country": "US", "domain_rank": 408, "title": "BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-16T15:38:00.000+02:00", "replies_count": 0, "uuid": "03e2b105d71cb61a5a6993c65de92dfca841add0"}, "author": "", "url": "https://www.reuters.com/article/brief-sun-pharmaceutical-industries-anno/brief-sun-pharmaceutical-industries-announces-settlement-of-patent-litigation-for-generic-linzess-in-u-s-idUSFWN1PB0UD", "ord_in_thread": 0, "title": "BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "brief-sun pharmaceutical industries", "sentiment": "negative"}, {"name": "generic linzess in u.s. reuters", "sentiment": "none"}, {"name": "reuters) - sun pharmaceutical industries ltd", "sentiment": "none"}, {"name": "allergan", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 39 PM / Updated 12 minutes ago BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S. Reuters Staff \nJan 16 (Reuters) - Sun Pharmaceutical Industries Ltd : \n* SAYS CO‘S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC \n* ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US \n* COMPANIES TO GRANT CO‘S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES \n* ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED. Source text - bit.ly/2Dl8eOU  ", "external_links": [], "published": "2018-01-16T15:38:00.000+02:00", "crawled": "2018-01-16T15:54:09.018+02:00", "highlightTitle": ""}